Myeloma, AL amyloidosis and COVID-19

A new Myeloma Patients Europe (MPE) website section on COVID-19 (coronavirus) has been created for the compilation of documents being generated at national and global level on the management of myeloma and AL amyloidosis patients during the COVID-19 outbreak.

Our main goal is to gather information and resources and make sure you have access to the latest details regarding COVID-19 and how it affects myeloma and AL amyloidosis patients and their treatment and care.















 

MPE is working also to develop useful information materials and resources for members and patients on COVID-19 (www.mpeurope.org/covid-19/covid-19-mpe-publications). If you feel there is a need for these materials to be translated into your language, please email vallejo@mpeurope.org.